Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up

Alzheimer’s drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.

Related Keywords

San Diego ,California ,United States ,Chris Viehbacher ,Eisai Leqembi ,European Union ,Wall Street ,Reata Pharmaceuticals ,Sage Therapeutics ,News ,